248 related articles for article (PubMed ID: 18829980)
1. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling.
Kallifatidis G; Rausch V; Baumann B; Apel A; Beckermann BM; Groth A; Mattern J; Li Z; Kolb A; Moldenhauer G; Altevogt P; Wirth T; Werner J; Schemmer P; Büchler MW; Salnikov AV; Herr I
Gut; 2009 Jul; 58(7):949-63. PubMed ID: 18829980
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane: from chemoprevention to pancreatic cancer treatment?
Lampe JW
Gut; 2009 Jul; 58(7):900-2. PubMed ID: 19520886
[No Abstract] [Full Text] [Related]
3. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
Khanbolooki S; Nawrocki ST; Arumugam T; Andtbacka R; Pino MS; Kurzrock R; Logsdon CD; Abbruzzese JL; McConkey DJ
Mol Cancer Ther; 2006 Sep; 5(9):2251-60. PubMed ID: 16985059
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
Rausch V; Liu L; Kallifatidis G; Baumann B; Mattern J; Gladkich J; Wirth T; Schemmer P; Büchler MW; Zöller M; Salnikov AV; Herr I
Cancer Res; 2010 Jun; 70(12):5004-13. PubMed ID: 20530687
[TBL] [Abstract][Full Text] [Related]
5. c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.
Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Häsler R; Rosenstiel P; Hauser C; Egberts JH; Trauzold A; Schneider G; Sipos B; Zeissig S; Schreiber S; Schäfer H; Arlt A
Cell Death Dis; 2014 Oct; 5(10):e1455. PubMed ID: 25299780
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis.
Shankar S; Ganapathy S; Srivastava RK
Clin Cancer Res; 2008 Nov; 14(21):6855-66. PubMed ID: 18980980
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death.
Thomas RP; Farrow BJ; Kim S; May MJ; Hellmich MR; Evers BM
Surgery; 2002 Aug; 132(2):127-34. PubMed ID: 12219002
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling.
Rasheduzzaman M; Jeong JK; Park SY
Life Sci; 2018 Sep; 208():208-220. PubMed ID: 30031063
[TBL] [Abstract][Full Text] [Related]
9. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5.
Kim H; Kim EH; Eom YW; Kim WH; Kwon TK; Lee SJ; Choi KS
Cancer Res; 2006 Feb; 66(3):1740-50. PubMed ID: 16452234
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells.
Labsch S; Liu L; Bauer N; Zhang Y; Aleksandrowicz E; Gladkich J; Schönsiegel F; Herr I
Int J Oncol; 2014 May; 44(5):1470-80. PubMed ID: 24626333
[TBL] [Abstract][Full Text] [Related]
12. Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance.
Bauer JA; Lupica JA; Didonato JA; Lindner DJ
Anticancer Res; 2020 Dec; 40(12):6751-6763. PubMed ID: 33288568
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-kappaB-DNA-binding activity in human bladder T24 cells.
Shan Y; Wu K; Wang W; Wang S; Lin N; Zhao R; Cassidy A; Bao Y
Int J Oncol; 2009 Apr; 34(4):1129-34. PubMed ID: 19287971
[TBL] [Abstract][Full Text] [Related]
14. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Szliszka E; Zydowicz G; Janoszka B; Dobosz C; Kowalczyk-Ziomek G; Krol W
Int J Oncol; 2011 Apr; 38(4):941-53. PubMed ID: 21286663
[TBL] [Abstract][Full Text] [Related]
15. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
16. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
[TBL] [Abstract][Full Text] [Related]
17. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
18. PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation.
Tanaka H; Hoshikawa Y; Oh-hara T; Koike S; Naito M; Noda T; Arai H; Tsuruo T; Fujita N
Mol Cancer Res; 2009 Apr; 7(4):557-69. PubMed ID: 19372584
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.
Omar HA; Arafa el-SA; Maghrabi IA; Weng JR
Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):464-71. PubMed ID: 24401154
[TBL] [Abstract][Full Text] [Related]
20. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
Deeb D; Jiang H; Gao X; Hafner MS; Wong H; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
Mol Cancer Ther; 2004 Jul; 3(7):803-12. PubMed ID: 15252141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
